Selective and nonselective benzodiazepine agonists have different effects on motor cortex excitability
- 5 April 2006
- journal article
- clinical trial
- Published by Wiley in Muscle & Nerve
- Vol. 33 (6) , 778-784
- https://doi.org/10.1002/mus.20531
Abstract
Transcranial magnetic stimulation (TMS) is a useful method to study pharmacological effects on motor cortex excitability. Zolpidem is a selective agonist of the benzodiazepine receptor subtype BZ1and has a distinct pharmacological profile compared to diazepam. To study the different effects of these two drugs on the cortical inhibitory system, TMS was performed before and after administration of a single oral dose of zolpidem (10 mg) and diazepam (5 mg) in six healthy volunteers. TMS tests included the determination of resting and active motor threshold (MT) and measurements of the amplitudes of motor evoked potentials, intracortical facilitation (ICF), short‐latency intracortical inhibition (SICI), and long‐latency intracortical inhibition (LICI), and determination of the cortical silent period (CSP). Both drugs were without effect on the active or resting MT and decreased the ICF. Prolongation of the CSP and enhancement of LICI only in the presence of zolpidem point to a specific BZ1‐related mechanism underlying the long‐lasting component of cortical inhibition. This selective modulation of the CSP and the LICI points to a specific role of BZ1receptors in the control of inhibitory neuronal loops within the primary motor cortex. Muscle Nerve, 2006Keywords
This publication has 34 references indexed in Scilit:
- TMS and drugsClinical Neurophysiology, 2004
- Unraveling the function of GABAA receptor subtypesTrends in Pharmacological Sciences, 2000
- Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humansThe Journal of Physiology, 1999
- Functional and pharmacological properties of GABA-mediated inhibition in the human neocortexCanadian Journal of Physiology and Pharmacology, 1997
- Transcranial magnetic stimulation: A useful tool for clinical neurophysiologyAnnals of Neurology, 1996
- Inhibition of human motor cortex by ethanol A transcranial magnetic stimulation studyBrain, 1995
- Biological function of GABAA/benzodiazepine receptor heterogeneityJournal of Psychiatric Research, 1995
- Recent developments in the behavioral pharmacology of benzodiazepine (ω) receptors: Evidence for the functional significance of receptor subtypesNeuroscience & Biobehavioral Reviews, 1994
- γ‐Aminobutyric AcidA Receptor α5‐Subunit Creates Novel Type II Benzodiazepine Receptor PharmacologyJournal of Neurochemistry, 1990
- Changes of transcranially evoked motor responses in man by midazolam, a short acting benzodiazepineNeuroscience Letters, 1989